<DOC>
	<DOCNO>NCT00639067</DOCNO>
	<brief_summary>To demonstrate validate breath test detection early stage lung cancer could potentially reduce number death .</brief_summary>
	<brief_title>Breath Test Early Detection Lung Cancer</brief_title>
	<detailed_description>This multicenter study compare several group subject without lung cancer CT scan , biopsy breath test . The breath test perform validate methodology predictive algorithm previously develop .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Group 1 Asymptomatic High Risk Subjects Inclusion criteria 1 . Patient willing able cooperate study give sign informed consent participate . 2 . Patient ( ) chest image spiral CT within 7 day breath test . 3 . Age least 18 year . 4 . History least 10 packyears cigarette smoking . 5 . Provide write informed consent prior admission study . Exclusion criteria 1 . Previously documented history cancer site . Group 2 Symptomatic High Risk Subjects Without Tissue Diagnosis Inclusion criteria 1 . Patient willing able cooperate study give sign informed consent participate . 2 . Patient tissue diagnosis pulmonary disease . 3 . Patient undergoing evaluation unexplained pulmonary illness clinically consistent lung cancer . This include patient unexplained symptom ( e.g . chronic unexplained cough hemoptysis ) , unexplained sign ( e.g . weight loss , lymphadenopathy ) unexplained investigation ( e.g . abnormal chest xray ) . 4 . Actively smoke patient , well never smoker former smoker eligible study long complete smoking consumption history record . Exclusion criteria 1 . Previously documented history cancer site . Group 3 Symptomatic High Risk Subjects Tissue Diagnosis Inclusion criteria 1 . Patient willing able cooperate study give sign informed consent participate . 2 . Patient tissue diagnosis a. lung cancer . b. pulmonary disease lung cancer e.g . sarcoidosis , COPD , pulmonary infection . 3 . A diagnosis lung cancer define cytologic histologic confirmation lung cancer bronchoscopic/thoracoscopic mean , sputum cytology , percutaneous fine needle aspiration biopsy . Patients may either nonsmall cell lung cancer small cell lung cancer . 4 . Breath VOC collection obtain prior invasive procedure e.g . thoracotomy , mediastinoscopy mediastinotomy . 5 . Actively smoke patient , well never smoker former smoker eligible study long complete smoking consumption history record . Exclusion criteria 1 . Previously documented history cancer site . Group 4 Apparently healthy subject Inclusion criterion 1 . Willingness follow protocol requirement evidence write , informed consent . 2 . Healthy , male female subject , age 18 older . 3 . Subjects non smoker sign symptom lung carcinoma Exclusion Criteria 1 . Any active ongoing medical problem .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Cancer Lung</keyword>
	<keyword>Cancer Lung</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>Neoplasms , Lung</keyword>
	<keyword>Neoplasms , Pulmonary</keyword>
	<keyword>Pulmonary Cancer</keyword>
	<keyword>Pulmonary Neoplasms</keyword>
</DOC>